Acute Communicable Disease Control

County of Los Angeles
Department of Public Health
Acute Communicable Disease Control
313 N. Figueroa Street, #212
Los Angeles, CA 90012
Phone: (213) 240-7941
Fax: (213) 482-4856
Email:acdc2@ph.lacounty.gov

Have questions about things like where to go for vaccinations or other health care services?

Call 2-1-1.

Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. If you are using an earlier version of Adobe Acrobat Reader (4.x or less), document functionality may be reduced.

Novel Multi-Drug Resistant Organisms

Local and national surveillance has identified novel forms of multi-drug resistant organisms (MDROs) that need to be detected and contained before they spread. Many of these organisms are difficult to treat, have been associated with international travel, and have the potential to spread rapidly.

Healthcare facilities and laboratories should contact the Acute Communicable Disease Control Program immediately when any of the following organisms are detected:

• Atypical Candida auris (such as echinocandin-or pan-resistant cases)
• Non-KPC-carbapenemase-producing Enterobacterales
• Carbapenemase-producing Acinetobacter baumanii
• Carbapenemase-producing Pseudomonas aeruginosa
• Vancomycin-resistant Staphylococcus aureus (VRSA)
• Pan-resistant organisms

Reporting Instructions

LACDPH MDRO Compliance Instructions (7-13-20) LACDPH MDRO Reporting FAQ's (7-13-20) LACDPH MDRO Reporting Webinar Slides (2-5-20)

LACDPH MDRO Reporting Webinar Recording (2-5-20)

Monthly MDRO Lab Newsletter

LAC DPH MDRO News Update for Laboratories #12 (05-05-23) LAC DPH MDRO News Update for Laboratories #11 (12-6-22) LAC DPH MDRO News Update for Laboratories #10 (7-29-22) LAC DPH MDRO News Update for Laboratories #9 (3-31-22) LAC DPH MDRO News Update for Laboratories #8 (11-1-21) LAC DPH MDRO News Update for Laboratories #7 (7-30-21) LAC DPH MDRO News Update for Laboratories #6 (6-30-21) LAC DPH MDRO News Update for Laboratories #5 (6-7-21) LAC DPH C. auris News Update for Laboratories #4 (4-30-21) LAC DPH C. auris News Update for Laboratories #3 (3-30-21) LAC DPH C. auris News Update for Laboratories #2 (2-10-21) LAC DPH C. auris News Update for Laboratories #1 (1-08-21)

Resources

	LAC DPH Transferring Guidance for MDROs - This document provides some guidance on how discharging and receiving facilities can ensure that each patient's MDRO status is clearly communicated during the transfer process.
	NDM-CRAB Transfer Recommendations and FAQs for Healthcare Facilities
	NDM-CRE Transfer Recommendations and FAQs
	N-MDRO Newsletter Spotlight on Candida auris
	N-MDRO Newsletter Issue I (January 2019) - Describes findings from our N-MDRO surveillance to date along with recommendations
	CPO Wallet Card: Healthcare facilities can provide this to patients/residents that are infected/colonized with a carbapenemase-producing organism (CPO) to remind them that they made need special precautions when receiving health care at a facility or at home.
	CDPH Enhanced Standard Precautions for Skilled Nursing Facilities (SNF), 2019: This updates guidance on safely caring for skilled-nursing facility residents suspected or known to be positive for multidrug-resistant organisms (MDRO).

Useful Links:
CDC Containment Strategy Responding to Emerging AR Threats
CDC Recommendations for Identification of Candida auris

See Also
Antibiotic Resistance
CPO